MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 75 filers reported holding MARKER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16 | -99.9% | 60,202 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | +120.0% | 60,202 | +100.0% | 0.00% | +100.0% |
| Q2 2022 | $10,000 | -23.1% | 30,101 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -55.2% | 30,101 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $29,000 | -43.1% | 30,101 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $51,000 | -39.3% | 30,101 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $84,000 | +25.4% | 30,101 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $67,000 | +52.3% | 30,101 | 0.0% | 0.01% | +50.0% |
| Q4 2020 | $44,000 | -2.2% | 30,101 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $45,000 | -27.4% | 30,101 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $62,000 | -56.9% | 30,101 | -50.0% | 0.01% | -25.0% |
| Q1 2020 | $144,000 | +65.5% | 60,202 | +100.0% | 0.01% | -11.1% |
| Q4 2019 | $87,000 | -43.5% | 30,101 | 0.0% | 0.01% | -43.8% |
| Q3 2019 | $154,000 | -35.3% | 30,101 | 0.0% | 0.02% | -36.0% |
| Q2 2019 | $238,000 | +19.6% | 30,101 | 0.0% | 0.02% | +19.0% |
| Q1 2019 | $199,000 | +19.2% | 30,101 | 0.0% | 0.02% | +5.0% |
| Q4 2018 | $167,000 | – | 30,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |